Enabling self-efficacy through digital technologies and innovative therapies
Patients have the tools to measure and record data and, increasingly, have access to innovative technologies and therapies that give them an active role in their care.
Enabling self-efficacy through digital technologies and innovative therapies
Patients have the tools to measure and record data and, increasingly, have access to innovative technologies and therapies that give them an active role in their care. This offers unprecedented opportunities for secondary prevention and behavioural changes and can spare people with diabetes from suffering complications that result from poor glucose control. But which digital health interventions could be most beneficial for people with diabetes? How can data sharing improve outcomes, reduce health system costs and support up-take of innovative approaches to diabetes management and care? What are the barriers that need to be overcome in order to benefit from innovative technologies and therapies?
In order to explore these questions and build consensus on possible policy solutions, EFPIA and vfa convened a multi-stakeholder roundtable in Berlin on 13 September 2019. The purpose was to share different stakeholder perspectives on the barriers and opportunities of digital tools and innovative therapies and to explore the value of innovation in improving diabetes care and outcomes.